Level of Asthma Controller Therapy Before Admission to the Hospital

Open Access
Authors
  • M. Belhassen
  • C. Langlois
  • L. Laforest
  • A.L. Dima
  • M. Ginoux
  • M. Sadatsafavi
  • E. Van Ganse
Publication date 2016
Journal Journal of Allergy and Clinical Immunology: In Practice
Volume | Issue number 4 | 5
Pages (from-to) 877-883
Number of pages 7
Organisations
  • Faculty of Social and Behavioural Sciences (FMG) - Amsterdam School of Communication Research (ASCoR)
  • Faculty of Social and Behavioural Sciences (FMG)
Abstract

BACKGROUND: In asthma, choice of controller therapy and adherence to treatment can affect the risk of future severe exacerbations leading to hospitalization.

OBJECTIVE: Our objective was to characterize treatment dispensation profiles before hospital admission for asthma.

METHODS: Using a 1/97th random sample of the national French claims data, patients with asthma aged 6 to 40 years were identified between 2006 and 2014. Patients with subsequent asthma-related hospitalization were selected. On the basis of controller therapy dispensed in the 12 months before admission, treatment profiles were categorized into clusters, using Ward's minimum-variance hierarchical clustering method.

RESULTS: Of 17,846 patients with asthma, we identified 275 patients (1.5%) with an asthma-related hospitalization. Three distinct clusters were identified. The first cluster (63.6%) included patients with few dispensations of any controller medication (<1 unit). The second cluster (32.4%) consisted of patients with frequent dispensations of long-acting beta agonists (LABAs)/inhaled corticosteroids (ICS) in fixed-dose combinations. The third cluster (4%) comprised patients receiving free combinations of ICS and LABAs, with more dispensations of LABAs than of ICS.

CONCLUSIONS: In France, before an asthma-related hospitalization, more than 60% of patients received little controller therapy and 4% were exposed to higher dispensation of LABAs than of ICS. These results indicate that a large fraction of asthma-related hospitalizations can potentially be prevented with better pharmacotherapy.

Document type Article
Language English
Published at https://doi.org/10.1016/j.jaip.2016.06.012
Downloads
Permalink to this page
Back